Curaleaf Files 6-K, Will Use Form 40-F for Annual Report

Ticker: CURLF · Form: 6-K · Filed: 2024-06-14T00:00:00.000Z

Sentiment: neutral

Topics: reporting, sec-filing, annual-report

TL;DR

Curaleaf filed a 6-K, confirming they'll use Form 40-F for their annual report.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on June 14, 2024, indicating it will file its annual report under Form 40-F. The filing also includes a press release as Exhibit 99.1, though the content of the press release is not detailed in this document.

Why It Matters

This filing signals Curaleaf's adherence to reporting requirements for foreign private issuers, specifically its intention to use Form 40-F for its annual report, which is common for Canadian companies.

Risk Assessment

Risk Level: low — This is a routine administrative filing confirming reporting procedures and not disclosing new material financial or operational information.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K is a report of a foreign private issuer filed for the month of June 2024, and it indicates that Curaleaf Holdings, Inc. will file its annual reports under cover of Form 40-F.

Which form will Curaleaf Holdings, Inc. use for its annual reports?

Curaleaf Holdings, Inc. will use Form 40-F for its annual reports, as indicated by the checkmark next to 'Form 40-F' in the filing.

Who signed this report on behalf of Curaleaf Holdings, Inc.?

The report was signed by Peter Clateman, Chief Legal Officer, on behalf of Curaleaf Holdings, Inc.

What is the filing date of this report?

This report was filed on June 14, 2024.

What exhibits are included with this 6-K filing?

Exhibit 99.1, a Press Release, is included with this 6-K filing.

From the Filing

0001756770-24-000042.txt : 20240614 0001756770-24-000042.hdr.sgml : 20240614 20240614165109 ACCESSION NUMBER: 0001756770-24-000042 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20240614 FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 241045643 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover061424.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June, 2024 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: June 14, 2024 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release 99.2 Report of Voting Results EX-99.1 2 pressrelease061424.htm EX-99.1 Document Curaleaf Reports on Voting Results from the 2024 Annual General Meeting of Shareholders   NEW YORK, June 14, 2024 – The Annual General Meeting of Shareholders of Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer cannabis products, was held today via live webcast online. Each of the matters voted upon at the meeting is discussed in detail in the Company’s management information circular dated May 6, 2024 (the “Circular”), which can be found under the Company’s profile on SEDAR+ (www.sedarplus.ca) and on EDGAR (https://www.sec.gov/edgar). The total number of votes cast by shareholders in person or represented by proxy at the meeting was 1,741,506,378 votes (with each subordinate voting share entitling the holder thereof to one vote, and each multiple voting share entitling the holder thereof to 15 votes). The voting results in relation to the election of directors were as follows: Percentage of Votes Name of Director For Withheld Boris Jordan 98.515 1.485 Joseph Lusardi 98.931 1.069 Dr. Jaswinder Grover 99.906 0.094 Karl Johansson 99.587 0.413 Peter Derby 99.253 0.747 Mitchell Kahn 98.736 1.264 Shasheen Shah 99.848 0.152 Michelle Bodner 98.873 1.127 In addition, the number of directors of the Company was also set by the shareholders of Curaleaf at 10 directors, and the resolution with respect to the reappointment of PKF O’Connor Davies, LLP as the Company’s auditor put before shareholders for consideration and approval at the meeting, as described in the Circular, was duly approved by the requisite number of votes. The Company has filed a report of voting results on all resolutions voted on at the meeting under its profile on www.sedarplus.ca and on www.sec.gov/edgar. About Curaleaf Holdings Curaleaf Holdings, Inc

View on Read The Filing